• Login
Fintedex — Business, Fincance & Investment News
  • Contact
  • About us
No Result
View All Result
  • Contact
  • About us
No Result
View All Result
Fintedex — Business, Fincance & Investment News
No Result
View All Result
Home Technology

Life sciences news roundup: Adaptive layoffs; Seattle Children’s biotech partnership; and more

Timothy Wilson by Timothy Wilson
29.09.2022
in Technology
0
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Adaptive’s HQ in Seattle. (GeekWire Photo)

As a bear market takes a bite out of biotech stock values that had soared during the pandemic, some companies are retrenching.

Adaptive Biotechnologies had recently doubled its headcount as it turned to COVID-19 projects, but on Wednesday the Seattle company laid off 12% of its workforce, about 100 employees. The public company is reorganizing to focus on two key areas: immune medicine and “minimal residual disease” cancer detection. Adaptive also hired a new CFO, Tycho Peterson.

“Given current market conditions affecting Adaptive and the biotech industry more broadly, we needed to ensure we had enough flexibility to meet our medium- to long-terms goals,” a spokesperson told GeekWire.

We’ve rounded up other recent life sciences and health tech news in the Pacific Northwest below:

Joyce Yen, head of the UW ADVANCE program. (UW Photo)

  • Joyce Yen recently won a $10,000 U.S. Presidential Award for her mentorship leading the University of Washington ADVANCE Center for Institutional Change. We spoke with her about how to lower barriers to recruiting and retaining women STEM faculty.
  • Seattle Children Therapeutics will advance its BrainChild CAR T cell therapies for central nervous system cancers into phase 2 trials in partnership with Cellevolve. Children’s investigator Dr. Michael Jensen, a co-founder of Umoja Biopharma, will become chair of the San Francisco company’s scientific advisory board, and Seattle Children’s will receive an equity stake.
  • Bothell, Wash.-based Cocrystal Pharma has dosed its first subjects in a phase 1 trial of a broad-spectrum oral antiviral agent for pandemic and seasonal influenza A.
  • Alpine Immune Sciences’ clinical trial for its immune modulator davoceticept, combined with the immune checkpoint drug Keytruda, was put on a partial hold while investigators assess a patient death in the study.   
  • Washington state partners with Seattle-based startup 2morrow to offer its smoking cessation app for free to state residents. A recent study showed the app is being used by a broad range of demographic groups — meanwhile, a measure to ban flavored vape products popular with kids died in the state legislature for the second year in a row.
  • Evergreen Bioscience, an organization working to make Washington state and the Intermountain Northwest a magnet for contract research and manufacturing was awarded $500,000 by Washington state’s Department of Commerce.
  • A new study from the Institute for Health Metrics and Evaluation tallied the overwhelming burden of the pandemic, concluding that 18.2 million people died worldwide from COVID-19 between the start of the pandemic and the end of last year, compared to the 5.94 million deaths officially reported.
  • Here’s a nice profile of a Portland biotech startup, Sparrow Pharmaceuticals, which is testing therapies to soften the effects of excess steroid levels, in phase 2 clinical trials.
  • University of Washington researchers have developed a device to detect the acidity of dental plaque using optical measurements. The readout may tell what area of the tooth is most at risk of developing a cavity, according to a new study.

Editor’s note: Charlotte Schubert previously worked as a science editor and writer at Seattle Children’s Therapeutics.


Previous Post

The Boys season 3 trailer delivers Supe-d up smackdowns and riotous reveals

Next Post

The Wall Street Journal: JPMorgan leads weekend effort to resolve global nickel crisis

Related Posts

Bondstream
Technology

Bondstream™ receives Prestigious Nomination for the 2023 Go Global Awards

by Lillie Hull
07.06.2023
This James Webb telescope image may be hiding more than just the stars
Technology

This James Webb telescope image may be hiding more than just the stars

by Timothy Wilson
29.09.2022
New God of War Ragnarok abilities revealed, including incinerating blades
Technology

New God of War Ragnarok abilities revealed, including incinerating blades

by Timothy Wilson
29.09.2022
DualSense Edge: everything you need to know about the PS5 pro controller
Technology

DualSense Edge: everything you need to know about the PS5 pro controller

by Timothy Wilson
29.09.2022
Bluehost vs GoDaddy: Two top web hosting providers compared
Technology

Bluehost vs GoDaddy: Two top web hosting providers compared

by Timothy Wilson
29.09.2022
Next Post

The Wall Street Journal: JPMorgan leads weekend effort to resolve global nickel crisis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • Business
  • Opinion
  • Stock Market
  • Technology
  • Без рубрики

Fintedex delivers real-time news about the financial industry: feature stories, industry developments, opinions plus the latest on people and trends.

Categories

  • Business
  • Opinion
  • Stock Market
  • Technology
  • Без рубрики

Recent Posts

  • Wizz Air Faces Share Price Decline as Earnings Outlook Takes a Hit
  • IHG’s Business Travel Revenue Surpasses Pre-Pandemic Levels
  • How to Create a Winning Small Business Marketing Plan

© 2021 Fintedex. Submit news release

No Result
View All Result
  • Contact
  • About us

© 2021 Fintedex. Submit news release

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?